Shanghai Hospital Development Center(Joint Breakthrough Project for New Frontier Technologies.Project No.SHDC 12015118);Science and Technology Commission of Shanghai Municipality(Project No.15411950102&15411950106);Natural Science Foundation of Shanghai(Project No.14ZR1407100)
Background: After deinitive chemoradiotherapy for non-metastatic nasopharyngeal carcinoma(NPC), more than 10% of patients will experience a local recurrence. Salvage treatments present signiicant challenges for locall...
supported by the National Natural Science Foundation of China(No.81472525 and 81572665);the Science and Technology Planning Project of Guangdong Province,China(No.2014A050503033)
Background:For patients with nasopharyngeal carcinoma(NPC) who undergo re-irradiation with intensity-modulated radiotherapy(IMRT),lethal nasopharyngeal necrosis(LNN) is a severe late adverse event.The purpose of this ...